A股異動 | 航天長峯連續兩日漲停 高端重症呼吸機正式上市
格隆匯3月23日丨航天長峯(600855.SH)連續兩日漲停,現報12.66元,暫成交1.29億元,最新總市值55億元。消息面上,航天長峯積極加快創新研究的步伐,研發出了一款高性能高品質的ICU級別重症呼吸機——新一代Athena 8500呼吸機,這款產品體積小,功能強大,同時具備有創通氣和無創通氣功能並且具備很多獨門通氣模式,適用於三甲、二甲的相關科室,成人和嬰幼兒等,此產品是國產呼吸機在重症ICU、呼吸科的有利補充。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.